ONST
ABBV icon

Old North State Trust’s AbbVie ABBV Stock Holding History

Old North State Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Sell
7,236
-33
-0.5% -$7.32K 0.93% 27
2025
Q4 		$1.66M Sell
7,269
-291
-4% -$66.3K 0.98% 26
2025
Q3 		$1.75M Buy
7,560
+76
+1% +$15.5K 1.07% 22
2025
Q2 		$1.39M Sell
7,484
-78
-1% -$14.5K 0.95% 24
2025
Q1 		$1.34M Hold
7,562
– – 0.86% 26
2024
Q4 		$1.34M Buy
7,562
+130
+2% +$23.9K 0.86% 26
2024
Q3 		$1.47M Buy
7,432
+95
+1% +$17.7K 1.19% 16
2024
Q2 		$1.26M Buy
7,337
+386
+6% +$63.9K 1.09% 19
2024
Q1 		$1.27M Buy
+6,951
New +$1.2M 1.07% 19
2023
Q3 		$1.23M Sell
8,269
-487
-6% -$71.5K 0.96% 23
2023
Q2 		$1.18M Buy
8,756
+522
+6% +$76.5K 0.87% 28
2023
Q1 		$1.31M Buy
8,234
+25
+0.3% +$3.82K 0.91% 22
2022
Q4 		$1.33M Buy
8,209
+243
+3% +$37.3K 0.87% 23
2022
Q3 		$1.07M Buy
7,966
+7,958
+99,475% +$1.14M 0.92% 25
2022
Q2 		$1.28K Hold
8
– – 1.17% 21
2022
Q1 		$1.32K Sell
8
-8,168
-100% -$1.19M 1.06% 25
2021
Q4 		$1.11M Buy
8,176
+1,659
+25% +$196K 0.79% 30
2021
Q3 		$703K Sell
6,517
-35
-0.5% -$4K 0.63% 35
2021
Q2 		$738K Buy
6,552
+137
+2% +$15.4K 0.56% 40
2021
Q1 		$694K Buy
6,415
+92
+1% +$9.84K 0.55% 41
2020
Q4 		$678K Buy
6,323
+249
+4% +$23.9K 0.52% 40
2020
Q3 		$532K Sell
6,074
-959
-14% -$90.3K 0.36% 48
2020
Q2 		$690K Buy
7,033
+110
+2% +$9.69K 0.44% 42
2020
Q1 		$528K Sell
6,923
-95
-1% -$8.09K 0.38% 50
2019
Q4 		$621K Sell
7,018
-13
-0.2% -$1.08K 0.33% 54
2019
Q3 		$532K Sell
7,031
-1,447
-17% -$99.2K 0.36% 58
2019
Q2 		$617K Sell
8,478
-1,940
-19% -$152K 0.45% 51
2019
Q1 		$839K Sell
10,418
-832
-7% -$68.1K 0.59% 39
2018
Q4 		$1.04M Buy
11,250
+271
+2% +$23.8K 1.06% 24
2018
Q3 		$1.04M Buy
+10,979
New +$1.04M 0.98% 24

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Old North State Trust's ABBV Position: Q1 2026 in Review

Old North State Trust reduced its AbbVie (ABBV) stake by 0.45% in Q1 2026, selling an estimated $7.32K and leaving 7,236 shares worth $1.57M. The position accounts for 0.93% of the portfolio, ranked #27.

Old North State Trust first reported a position in ABBV in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.75M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Old North State Trust held 7,236 shares of AbbVie worth $1.57M as of Q1 2026.
  • Old North State Trust sold 33 AbbVie shares in Q1 2026, an estimated $7.32K.
  • AbbVie made up 0.93% of Old North State Trust's portfolio in Q1 2026, its #27 holding.
  • Old North State Trust first reported a position in AbbVie in Q3 2018 and has held it in 30 quarters since.
  • Old North State Trust's AbbVie position peaked at $1.75M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Old North State Trust's 13F filing for Q1 2026, filed 13 May 2026.